UPDATE: Janney Capital Markets Initiates Coverage on Impax Laboratories as The Last Mid-Cap Generics Company Standing
UPDATE: Janney Capital Markets Initiates Coverage on Durata Therapeutics on Fundamentally Changing Antibiotic Treatment
UPDATE: Janney Capital Markets Initiates Coverage on Impax Laboratories as The Last Mid-Cap Generics Company Standing
UPDATE: Janney Capital Markets Initiates Coverage on Durata Therapeutics on Fundamentally Changing Antibiotic Treatment
UPDATE: Janney Capital Markets Initiates Coverage on Flamel Technologies SA on Transition to Positive Earnings & Cash Flow